banner
HCV protease inhibitor Beclabuvir, Purity ≥98%

Cat. No.: X24-07-ZQ163

HCV protease inhibitor Beclabuvir, Purity ≥98%

Synonym: 958002-33-0; HCV protease inhibitor; BMS-791325; BMS791325; BMS 791325

  • CAS Number: 958002-33-0
  • Compound CID: 49773361
Product Size
1 mg; 5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Beclabuvir targets and inhibits the function of the hepatitis C virus protease enzyme.
Molecular Weight
659.84
Molecular Formula
C36H45N5O5S
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Beclabuvir is an investigational HCV protease inhibitor used to study its effects on Hepatitis C virus replication.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0